MISS HYUN JIN LEE, RPH
Pharmacy at La Jolla Village Dr, San Diego, CA
License number
California 018776
Category
Pharmacy
Type
Pharmacist
Address
Address
3350 La Jolla Village Dr, San Diego, CA 92161
Phone
(858) 642-1616
(858) 245-9057
(858) 245-9057
Personal information
See more information about HYUN JIN LEE at radaris.comName
Address
Phone
4333 Morgan Creek Way, Oceanside, CA 92057
432 S Norton Ave, Los Angeles, CA 90020
438 E Newmark Ave APT B, Monterey Park, CA 91755
4327 Toland Way APT 206, Los Angeles, CA 90041
4305 Pennsylvania Ave APT 8, Glendale, CA 91214
Professional information
Compounds And Compositions As Protein Kinase Inhibitors
US Patent:
2009010, Apr 23, 2009
Filed:
Jan 19, 2006
Appl. No.:
11/814912
Inventors:
Taebo Sim - San Diego CA, US
Nathanael Schiander Gray - San Diego CA, US
Hyun Soo Lee - San Diego CA, US
Yi Liu - San Diego CA, US
Pingda Ren - San Diego CA, US
Shuli You - San Diego CA, US
Qiong Zhang - San Diego CA, US
Qiang Ding - San Diego CA, US
Xia Wang - San Diego CA, US
Songchun Jiang - San Diego CA, US
Pamela A. Albaugh - Carlsbad CA, US
Nathanael Schiander Gray - San Diego CA, US
Hyun Soo Lee - San Diego CA, US
Yi Liu - San Diego CA, US
Pingda Ren - San Diego CA, US
Shuli You - San Diego CA, US
Qiong Zhang - San Diego CA, US
Qiang Ding - San Diego CA, US
Xia Wang - San Diego CA, US
Songchun Jiang - San Diego CA, US
Pamela A. Albaugh - Carlsbad CA, US
Assignee:
IRM LLC - Hamilton BM
International Classification:
A61K 31/427, C07D 277/56, C07D 417/14, C07D 417/12, A61K 31/454, A61K 31/506, A61K 31/5377, A61K 31/426
US Classification:
5142358, 548195, 544295, 544369, 544133, 544328, 544122, 546209, 51425219, 5142368, 514370, 514256, 514326, 51425402
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, Bcr-Abl, FGFR3, PDGFRβ and b-Raf kinases.
Compounds And Compositions As Protein Kinase Inhibitors
US Patent:
7371750, May 13, 2008
Filed:
Jul 29, 2004
Appl. No.:
10/909227
Inventors:
Taebo Sim - San Diego CA, US
Hyun Soo Lee - San Diego CA, US
Pingda Ren - San Diego CA, US
Qiang Ding - San Diego CA, US
Guobao Zhang - San Diego CA, US
Yi Liu - San Diego CA, US
Xia Wang - San Diego CA, US
Tetsuo Uno - San Diego CA, US
Bing Li - San Diego CA, US
Lintong Li - San Diego CA, US
Nathanael Schiander Gray - San Diego CA, US
Shuli You - San Diego CA, US
Hyun Soo Lee - San Diego CA, US
Pingda Ren - San Diego CA, US
Qiang Ding - San Diego CA, US
Guobao Zhang - San Diego CA, US
Yi Liu - San Diego CA, US
Xia Wang - San Diego CA, US
Tetsuo Uno - San Diego CA, US
Bing Li - San Diego CA, US
Lintong Li - San Diego CA, US
Nathanael Schiander Gray - San Diego CA, US
Shuli You - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
A61K 31/5355, A61K 31/53, A61K 31/497, A61K 31/513, C07D 413/12, C07D 253/065, C07D 487/04, C07D 413/14, A61P 35/00, C07D 471/04
US Classification:
5142342, 514242, 51425216, 5142621, 544112, 544118, 544182, 544256, 544279, 544 81
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, Bmx, c-Raf, Csk, Fes, FGFR, Flt3, Ikk, IR, JNK, Lck, Mkk, PKC, PKD, Rsk, SAPK, Syk, Trk, BTK, Src, EGFR, IGF, Mek, Ros and Tie2 kinases.
Compounds And Compositions As Protein Kinase Inhibitors
US Patent:
7642255, Jan 5, 2010
Filed:
Apr 8, 2008
Appl. No.:
12/099708
Inventors:
Taebo Sim - Seoul, KR
Hyun Soo Lee - San Diego CA, US
Pingda Ren - San Diego CA, US
Qiang Ding - San Diego CA, US
Yi Liu - San Diego CA, US
Bing Li - Westborough MA, US
Lintong Li - San Diego CA, US
Xia Wang - San Diego CA, US
Tetsuo Uno - San Diego CA, US
Guobao Zhang - San Diego CA, US
Nathanael Schiander Gray - Boston MA, US
Shuli You - Shanghai, CN
Hyun Soo Lee - San Diego CA, US
Pingda Ren - San Diego CA, US
Qiang Ding - San Diego CA, US
Yi Liu - San Diego CA, US
Bing Li - Westborough MA, US
Lintong Li - San Diego CA, US
Xia Wang - San Diego CA, US
Tetsuo Uno - San Diego CA, US
Guobao Zhang - San Diego CA, US
Nathanael Schiander Gray - Boston MA, US
Shuli You - Shanghai, CN
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 413/14, C07D 471/04, C07D 487/04, A61K 31/535, A61K 31/497, A61K 31/519, C07D 251/12, A61K 31/53, A61P 35/00
US Classification:
5142342, 514241, 51425505, 51425216, 5142641, 51425214, 5142621, 544279, 544117, 544215, 544256, 544118
Abstract:
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, Bmx, c-Raf, Csk, Fes, FGFR, Flt3, Ikk, IR, JNK, Lck, Mkk, PKC, PKD, Rsk, SAPK, Syk, Trk, BTK, Src, EGFR, IGF, Mek, Ros and Tie2 kinases.